Anti-mouse NK1.1-InVivo

目录号：A2114         批次号: A211416

       克隆号：PK136

打印

PK136单克隆抗体（克隆号：PK136）与小鼠NK1.1（也称为CD161b/CD161c，KLRB1，NKR-P1A和Ly-55）反应。

抗体信息

克隆号 PK136
免疫原 Mouse spleen and bone marrow cells enriched for NK1+ cells
配制 PBS buffer, pH 7.0
推荐同型对照 Mouse IgG2a,κ
应用 in vivo NK cell depletion,FCM
来源 CHO
小鼠病原体检测 all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus.
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 7.23 mg/ml
内毒素 ＜1EU/mg

客户使用selleck产品的实验数据

Anti-mouse NK1.1-InVivo在文献中得到引用

Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy [ Nature Communications, November 25, 2025, 16(1):11622] PubMed: 41290746
Epidermal MHC-II-mediated NK cell recruitment triggers keratinocyte pyroptosis, facilitating pathogenesis of psoriasis [ Experimental & Molecular Medicine, May 8, 2026, 58(5):1573-1588] PubMed: 42104015
A Probiotic Approach Targeting Hypersialylation Revives CD8+ T-cell Immunity and Boosts Photodynamic Therapy Efficacy in Solid Tumors [ Cancer Research, May 14, 2026, 2915-2934] PubMed: 42133438
A Probiotic Approach Targeting Hypersialylation Revives CD8+ T-cell Immunity and Boosts Photodynamic Therapy Efficacy in Solid Tumors [ Cancer Research, May 14, 2026, OF1-OF20] PubMed: 42133438
Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation [ Molecular Therapy Advances, June 1, 2026, 34(2):201742] PubMed: 42164241
NK cell-derived GZMB (granzyme B) suppresses glioblastoma radioresistance by blocking SDC1-mediated autophagosome maturation [ Autophagy, January 9, 2026, 22(3):545-566] PubMed: 41378763
Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy [ BMC Medicine, January 30, 2026, 127] PubMed: 41612317
Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy [ BMC Medicine, January 30, 2026, 24(1):127] PubMed: 41612317
Glycoliposomes target lymphatic dendritic cells in a size-dependent manner to activate natural killer T cells against breast tumors [ Journal of Controlled Release, December 1, 2025, 388:114274] PubMed: 41016478
Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in Lung Cancer by Dendritic Cells [ Journal of Thoracic Oncology, August 1, 2025, 20(8):1050-1074] PubMed: 40056978

禁止用于人体及治疗！